Literature DB >> 18042696

Epstein-Barr virus and Burkitt lymphoma.

G Brady1, G J MacArthur, P J Farrell.   

Abstract

Burkitt lymphoma (BL) is an aggressive B-cell malignancy with endemic, sporadic and immunodeficiency-associated variants. It has been known for many years that the fundamental transforming event in BL is the translocation of the MYC gene, and the events that bring about this translocation and those that allow cells to survive with the constitutive expression of MYC have been the subject of intense investigation. Epstein-Barr virus (EBV) infection, malaria, immunodeficiency and spontaneous, somatic mutation can all contribute to the origin and maintenance of this cancer and their mechanisms are the subject of this review.

Entities:  

Mesh：

Year:  2007        PMID： 18042696      PMCID： PMC2095571          DOI： 10.1136/jcp.2007.047977

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  133 in total

Review 1.  Endemic Burkitt's lymphoma: a polymicrobial disease?

Authors:  Rosemary Rochford; Martin J Cannon; Ann M Moormann
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

2.  Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.

Authors:  Carol Anne Ogden; John D Pound; Balvinder K Batth; Sarah Owens; Ingolfur Johannessen; Katrina Wood; Christopher D Gregory
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

3.  Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

Authors:  G L Shen-Ong; E J Keath; S P Piccoli; M D Cole
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

4.  NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.

Authors:  L Ji; M Arcinas; L M Boxer
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

5.  IL-10 inhibits HIV-1 replication and is induced by tat.

Authors:  R Masood; Y Lunardi-Iskandar; T Moudgil; Y Zhang; R E Law; C L Huang; R K Puri; A M Levine; P S Gill
Journal:  Biochem Biophys Res Commun       Date:  1994-07-15       Impact factor: 3.575

6.  The discovery of Burkitt's lymphoma.

Authors:  D P Burkitt
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

7.  A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.

Authors:  J Wiels; G M Lenoir; M Fellous; M Lipinski; J C Salomon; C Tetaud; T Tursz
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

8.  Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

Authors:  R Khanna; S R Burrows; V Argaet; D J Moss
Journal:  Int Immunol       Date:  1994-04       Impact factor: 4.823

9.  A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

Authors:  D J Moss; S R Burrows; D J Castelino; R G Kane; J H Pope; A B Rickinson; M P Alpers; P F Heywood
Journal:  Int J Cancer       Date:  1983-06-15       Impact factor: 7.396

10.  Mitogenic activity of extracts from continuous cultures of Plasmodium falciparum.

Authors:  A A Gabrielsen; J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345
View more
  68 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma.

Authors:  Adele P Williams; Jerry E Stewart; Laura L Stafman; Jamie M Aye; Elizabeth Mroczek-Musulman; Changchun Ren; Karina Yoon; Kimberly Whelan; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2018-10-22       Impact factor: 2.545

3.  ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.

Authors:  Karen S Hathcock; Hesed M Padilla-Nash; Jordi Camps; Dong-Mi Shin; Daniel Triner; Arthur L Shaffer; Robert W Maul; Seth M Steinberg; Patricia J Gearhart; Louis M Staudt; Herbert C Morse; Thomas Ried; Richard J Hodes
Journal:  Blood       Date:  2015-09-23       Impact factor: 22.113

4.  Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines.

Authors:  Bochra Gargouri; Jos Van Pelt; Abd El Fatteh El Feki; Hammadi Attia; Saloua Lassoued
Journal:  Mol Cell Biochem       Date:  2008-12-11       Impact factor: 3.396

5.  Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.

Authors:  Lisa Giulino-Roth; Herman J van Besien; Tanner Dalton; Jennifer E Totonchy; Anna Rodina; Tony Taldone; Alexander Bolaender; Hediye Erdjument-Bromage; Jouliana Sadek; Amy Chadburn; Matthew J Barth; Filemon S Dela Cruz; Allison Rainey; Andrew L Kung; Gabriela Chiosis; Ethel Cesarman
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

6.  Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Authors:  Walter Lucchesi; Gareth Brady; Oliver Dittrich-Breiholz; Michael Kracht; Rainer Russ; Paul J Farrell
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

7.  Epstein-Barr virus induces morphological and molecular changes in thyroid neoplastic cells.

Authors:  Jacqueline Fátima Martins Almeida; José Luiz Proenca-Modena; Natássia Elena Bufalo; Karina Colombera Peres; Elisângela de Souza Teixeira; Larissa Teodoro; Raíssa Marques Beck; Ana Paula Moraes; Alfio José Tincani; Clarice Weis Arns; Laura Sterian Ward
Journal:  Endocrine       Date:  2020-03-12       Impact factor: 3.633

8.  CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.

Authors:  Stephanie N Hurwitz; Dingani Nkosi; Meghan M Conlon; Sara B York; Xia Liu; Deanna C Tremblay; David G Meckes
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

9.  An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Authors:  Gemma L Kelly; Heather M Long; Julianna Stylianou; Wendy A Thomas; Alison Leese; Andrew I Bell; Georg W Bornkamm; Josef Mautner; Alan B Rickinson; Martin Rowe
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

10.  EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier.

Authors:  Brady Beltran; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Esther Cotrina; Luis Riva; Jorge Castillo
Journal:  Infect Agent Cancer       Date:  2009-07-06       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.